ID

14835

Descripción

Bendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL); ODM derived from: https://clinicaltrials.gov/show/NCT01423032

Link

https://clinicaltrials.gov/show/NCT01423032

Palabras clave

  1. 1/5/16 1/5/16 -
Subido en

1 de mayo de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Chronic Lymphocytic Leukemia NCT01423032

Eligibility Chronic Lymphocytic Leukemia NCT01423032

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or immunologically confirmed chronic b-cell leukemia
Descripción

ID.1

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0023434
UMLS CUI [1,2]
C0019638
refractory (i.e. no response or progression during initial chemotherapy) or relapsed situation after first-line treatment regimen
Descripción

ID.2

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0278791
UMLS CUI [2]
C0277556
disease stage ii-iv according to rai or b/c according to binet staging system, respectively
Descripción

ID.3

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1511118
UMLS CUI [2]
C1514715
eastern cooperative oncology group (ecog) performance status of 3 or better
Descripción

ID.4

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
negative pregnancy test/ adequate method of contraception
Descripción

ID.5

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0700589
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
t-cll, pll (prolymphocytic leukemia)
Descripción

ID.6

Tipo de datos

boolean

presence of richter's transformation
Descripción

ID.7

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0349631
first-line treatment containing either fludarabine or bendamustine
Descripción

ID.8

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0059985
UMLS CUI [2]
C0525079
acute infections or distinctly reduced organ function precluding the application of chemotherapy, as for pulmonary, heart, liver (total bilirubin > 5mg/dl), renal system (creatinine > 2 mg/dl), or metabolic disorders
Descripción

ID.9

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0275518
UMLS CUI [2]
C0025517
UMLS CUI [3]
C0678852
secondary malignancy (except for curative treated basal cell carcinoma or cervical cancer)
Descripción

ID.10

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3266877

Similar models

Eligibility Chronic Lymphocytic Leukemia NCT01423032

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
histologically or immunologically confirmed chronic b-cell leukemia
boolean
C0023434 (UMLS CUI [1,1])
C0019638 (UMLS CUI [1,2])
ID.2
Item
refractory (i.e. no response or progression during initial chemotherapy) or relapsed situation after first-line treatment regimen
boolean
C0278791 (UMLS CUI [1])
C0277556 (UMLS CUI [2])
ID.3
Item
disease stage ii-iv according to rai or b/c according to binet staging system, respectively
boolean
C1511118 (UMLS CUI [1])
C1514715 (UMLS CUI [2])
ID.4
Item
eastern cooperative oncology group (ecog) performance status of 3 or better
boolean
C1520224 (UMLS CUI [1])
ID.5
Item
negative pregnancy test/ adequate method of contraception
boolean
C0032961 (UMLS CUI [1])
C0700589 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
ID.6
Item
t-cll, pll (prolymphocytic leukemia)
boolean
ID.7
Item
presence of richter's transformation
boolean
C0349631 (UMLS CUI [1])
ID.8
Item
first-line treatment containing either fludarabine or bendamustine
boolean
C0059985 (UMLS CUI [1])
C0525079 (UMLS CUI [2])
ID.9
Item
acute infections or distinctly reduced organ function precluding the application of chemotherapy, as for pulmonary, heart, liver (total bilirubin > 5mg/dl), renal system (creatinine > 2 mg/dl), or metabolic disorders
boolean
C0275518 (UMLS CUI [1])
C0025517 (UMLS CUI [2])
C0678852 (UMLS CUI [3])
ID.10
Item
secondary malignancy (except for curative treated basal cell carcinoma or cervical cancer)
boolean
C3266877 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial